InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
+2.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Miller Joseph M, Chief Financial Officer. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 8 reports have been logged. Breakdown: 2 buys · 2 sells. Total volume traded: €289k. History available since 11 May 2021. The latest transaction was filed on 28 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
81,457 shares0Common StockSEC:0001600620-25-000020:0
34,811 shares@ US$5.6062.0% of flowCommon StockSEC:0001600620-24-000037:0
11,398 shares@ US$8.7832.4% of flowCommon StockSEC:0001600620-24-000014:0
196,153 shares0Common StockSEC:0001600620-24-000018:0
229,421 sharesCommon StockSEC:0001628280-23-006531:0
8,500 shares0Common StockSEC:0001628280-22-005127:0
1,000 shares@ US$9.7450.0% of flowCommon StockSEC:0001628280-21-009835
Ideal exit: 5 Feb 2022 (T+270)
1,000 shares@ US$9.740.0004% mcap50.0% of flowCommon StockSEC:0001628280-21-009835:0
Ideal exit: 5 Feb 2022 (T+270)
8 of 8 declarations
About Miller Joseph M
Joseph M. Miller serves as Chief Financial Officer at Aurinia Pharmaceuticals Inc. He oversees the company's financial operations, ensuring compliance and transparency in reporting. Joseph is recognized for his expertise in financial management and his ability to support growth and innovation.
